CC
IMUX icon

Commodore Capital’s Immunic IMUX Stock Holding History

Commodore Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-180,000
Closed -$2.52M – 36
2022
Q4 		$2.52M Buy
180,000
+90,699
+102% +$2.47M 0.38% 32
2022
Q3 		$2.82M Hold
89,301
– – 0.45% 27
2022
Q2 		$3.1M Hold
89,301
– – 0.66% 20
2022
Q1 		$10.1M Buy
+89,301
New +$10.3M 2.25% 16

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Commodore Capital's IMUX Position: Q1 2023 in Review

Commodore Capital sold out of Immunic (IMUX) in Q1 2023, closing a stake of 180,000 shares — an estimated $2.52M sold.

Commodore Capital first reported a position in IMUX in Q1 2022 and held it in 4 quarters. The position peaked at $10.1M in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q1 2023.

  • Commodore Capital reported no remaining Immunic position as of Q1 2023 after selling out during the quarter.
  • Commodore Capital sold 180,000 Immunic shares in Q1 2023, an estimated $2.52M.
  • Commodore Capital first reported a position in Immunic in Q1 2022 and held it in 4 quarters.
  • Commodore Capital's Immunic position peaked at $10.1M in Q1 2022.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q1 2023.

Based on Commodore Capital's 13F filing for Q1 2023, filed 15 May 2023.